OpenVSafe by OpenVAERS
Search V-safe

L2Y-79524-38819

3 vaccinations 4 coded responses 14 check-ins 2 free-text entries 0 call cases
Sex
Male
Age at first dose
0-4
ZIP prefix
641 / MO
Registered
2022-10-03
Relationship
Child or adolescent in my care
Guardian
UKF-26954-86042
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2022-10-03
    Registered in v-safe
  2. 2022-10-07
    Dose 1 — Pfizer-BioNTech
    Co-administered: Flu
  3. 2022-10-07
    Health check-in — day 0, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  4. 2022-10-08
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · Site: Swelling/hardness · None
    Under 3 check-in
  5. 2022-10-10
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · Site: Swelling/hardness · Irritability/crying
    Under 3 check-in
  6. 2022-10-11
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  7. 2022-10-21
    Survey response — day 14, dose 1, under 3
    MedDRA: Cough — Feeling: Good
    Free text: Cough
    MedDRA releases: 2024-11 · check-in free text available
  8. 2022-11-04
    Health check-in — day 28, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  9. 2022-11-11
    Health check-in — day 35, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  10. 2022-12-08
    Dose 2 — Pfizer-BioNTech
  11. 2022-12-27
    Survey response — day 14, dose 2, under 3
    MedDRA: Cough, Rhinorrhoea — Feeling: Good
    Free text: Runny nose, cough
    MedDRA releases: 2024-11 · check-in free text available
  12. 2022-12-29
    Health check-in — day 21, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  13. 2023-01-19
    Health check-in — day 42, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  14. 2023-02-13
    Dose 3 — Pfizer-BioNTech
  15. 2023-02-13
    Health check-in — day 0, dose 3, under 3
    Feeling: Good · Site: Redness, Swelling/hardness · Irritability/crying
    Under 3 check-in
  16. 2023-02-14
    Health check-in — days 1–6 daily, dose 3, under 3
    Feeling: Good · Site: Redness · None
    Under 3 check-in
  17. 2023-02-22
    Survey response — day 7, dose 3, under 3
    MedDRA: Cough — Feeling: Fair · Fever
    MedDRA releases: 2024-11
  18. 2023-03-28
    Survey response — day 42, dose 3, under 3
    MedDRA: Gastrointestinal viral infection, Nasopharyngitis, Respiratory tract congestion — Feeling: Good · Be unable to work or attend school
    MedDRA releases: 2024-11

Vaccinations

DoseDateManufacturerCo-administered
12022-10-07Pfizer-BioNTech Flu
22022-12-08Pfizer-BioNTech No
32023-02-13Pfizer-BioNTech No

Free text

Release 12 (Under 3) — day 14, dose 1, under 3

2022-10-21

Symptoms: Cough

Release 12 (Under 3) — day 14, dose 2, under 3

2022-12-27

Symptoms: Runny nose, cough

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCough · · ✓
SDGastrointestinal viral infection · · ✓
SDNasopharyngitis · · ✓
SDRespiratory tract congestion · · ✓
SDRhinorrhoea · · ✓
SROCough · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…